NASDAQ:SLS

Sellas Life Sciences Group Stock Predictions

etoro logo Buy SLS
*Your capital is at risk
$8.23
-0.81 (-8.96%)
At Close: Jun 05, 2026
Currently predicting for Mon, 8 Jun 2026

SLS Prediction Chart

SLS Predictions History

Latest community submissions for SLS.
Predictor Target Session Target Price Result Direction Accuracy Score
May 19, 2025 $1.60 -1.92% $1.75 X 91.35% 0
May 9, 2025 $1.72 +2.63% $1.56 X 89.47% 0
May 9, 2025 $1.65 -1.65% $1.56 V 94.08% 1
May 7, 2025 $1.67 -2.69% $1.71 V 97.88% 1
May 7, 2025 $1.69 -1.68% $1.71 V 98.89% 2
May 6, 2025 $1.67 -2.61% $1.72 X 96.82% 0
May 6, 2025 $1.68 -1.63% $1.72 X 97.80% 0
May 1, 2025 $1.51 -2.50% $1.62 X 93.29% 0
May 1, 2025 $1.53 -1.56% $1.62 X 94.19% 0
Apr 30, 2025 $1.39 -2.57% $1.55 X 89.89% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for SLS with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT SELLAS LIFE SCIENCES GROUP INC.
SELLAS Life Sciences Group
SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the treatment of acute myeloid leukemia; and in Phase 1/2 clinical trials for the treatment for ovarian cance...
GOLDEN STAR
Ticker Change Signal Date
FISV
0% Nov 30
K
KEEL
0% Nov 30
D
DFTX
0% Nov 30
R
RKLZ
0% Nov 30
R
RKTO
0% Nov 30

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE